Lataa...
The potential of the estimands framework for clinical pharmacology trials: Some discussion points
The recently finalised and published guideline ICH E9 (R1) introduced a new framework for the statistical analysis of clinical trials, namely that of “estimands”. While the framework was originally developed for the analysis of late‐phase trials, it could also provide a rigorous basis for the analys...
Tallennettuna:
| Julkaisussa: | Br J Clin Pharmacol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7319003/ https://ncbi.nlm.nih.gov/pubmed/32030776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14233 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|